Satsuma Pharmaceuticals, Inc.
STSA · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $29 | $131 | $80 | $115 |
| - Cash | $16 | $16 | $36 | $23 |
| + Debt | $0 | $1 | $3 | $5 |
| Enterprise Value | $13 | $117 | $47 | $98 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$58 | -$51 | -$46 | -$27 |
| % Margin | – | – | – | – |
| Net Income | -$69 | -$51 | -$48 | -$29 |
| % Margin | – | – | – | – |
| EPS Diluted | -2.16 | -1.76 | -2.74 | -4.86 |
| % Growth | -22.7% | 35.8% | 43.6% | – |
| Operating Cash Flow | -$52 | -$43 | -$42 | -$30 |
| Capital Expenditures | -$0 | -$2 | -$5 | -$1 |
| Free Cash Flow | -$52 | -$45 | -$47 | -$30 |